Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin)
Be the first to review this product! Submit a review
|
(51 Publications)
Apoptosis Western Blot Cocktail (pro/cleaved Caspase-3, cleaved PARP1, Muscle Actin) (ab136812). For detection of the apoptosis biomarkers Caspase 3 and cleaved PARP, along with the loading control muscle actin.
- Cited in over 30 publications
View Alternative Names
CPP32, CASP3, Caspase-3, CASP-3, Apopain, Cysteine protease CPP32, Protein Yama, SREBP cleavage activity 1, CPP-32, SCA-1, ACTC, ACTC1, Alpha-cardiac actin, ADPRT, PPOL, PARP1, Poly [ADP-ribose] polymerase 1, PARP-1, ADP-ribosyltransferase diphtheria toxin-like 1, DNA ADP-ribosyltransferase PARP1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1, Protein poly-ADP-ribosyltransferase PARP1, ARTD1, ADPRT 1
- WB
Supplier Data
Western blot - Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin) (AB136812)
Lanes 1, 3, 5, 7 : (ab136806) HeLa, vehicle treated
Lanes 2, 4, 6, 8 : (ab136806) HeLa, 1 µM staurosporine (ab120056), 4 hours
All lysates at 20 µg per lane.
Primary antibodies
Lanes 1, 2 : Cleaved PARP
Lanes 3, 4 : Actin
Lanes 5, 6 : Caspase 3
Lanes 7, 8 : ab136812 250X Primary Antibodies Cocktail, 1/250 dilution
Secondary antibodies
All lanes : ab136812 100X HRP-Conjugated Secondary Antibodies Cocktail, 1/100 dilution.
false
- WB
Supplier Data
Western blot - Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin) (AB136812)
Lane 1 : Jurkat cells, untreated
Lane 2 : Jurkat cells treated with anti-FAS for 2 hours
Lane 3 : Jurkat cells treated with anti-FAS for 4 hours
Lane 4 : Jurkat cells treated with anti-FAS for 6 hours
All lysates at 20 μg/lane
Primary antibodies
All lanes : 250X Primary Antibodies Cocktail, 1/250 dilution.
Secondary antibodies
All lanes : 100X HRP-Conjugated Secondary Antibodies Cocktail (ab136812), 1/100 dilution.
false
Reactivity data
Product details
ab136812 contains a cocktail of primary antibodies for the detection of apoptosis biomarkers caspase 3 and PARP, along with loading control muscle actin (42 kDa). The caspase 3 antibody (rabbit monoclonal) detects both the 32 kDa pro-caspase 3 as well as the p17 subunit of active caspase 3 generated by cleavage of the pro-caspase 3 at Asp175. The PARP antibody (mouse monoclonal) detects only the apoptosis-specific 89 kDa PARP fragment (cleaved-PARP) generated from the full length PARP by active caspases. Since the primary antibodies used are both mouse and rabbit, a secondary antibodies cocktail of GAM-HRP and GAR-HRP is provided.
The Apoptosis western blot cocktail (ab136812) is designed to study the induction of apoptosis in response to various stimuli. The two main components of this cocktail are monoclonal antibodies specific to caspase 3 and PARP. Caspase 3 is one of the executioner caspases activated by proteolytic cleavage during apoptosis. The rabbit caspase 3 antibody of this cocktail detects both the 32 kDa pro-caspase 3 as well as the p17 subunit of the active caspase 3 generated by cleavage of the pro-caspase 3 at Asp175. Thus the induction of apoptosis can be followed by a decrease of the pro-caspase 3 or by an increase of the p17 caspase 3. Monitoring the changes in the pro-caspase 3 is particularly advantageous, since the proportion of caspase activation can be determined from the reduction of the pro-form from analysis of control and stimulated samples. Poly [ADP-ribose] polymerase 1 (PARP) is a DNA repair enzyme that is cleaved during apoptosis by activated caspases. The mouse PARP antibody of this cocktail detects only the apoptosis-specific 89 kDa PARP fragment (cleaved-PARP). This antibody does not react with the full-length PARP. Combined, these two antibodies provide biomarkers of apoptosis. The rabbit muscle actin antibody is provided as a loading control for sample to sample normalization. Since the primary antibodies are both mouse and rabbit, the cocktail of HRP-conjugated goat anti-rabbit and anti-mouse secondary antibodies is provided for convenience. The targets are easily resolved by Western blot given their different molecular weights.
Properties and storage information
Shipped at conditions
Appropriate long-term storage conditions
Target data
Additional targets
Publications (51)
Recent publications for all applications. Explore the full list and refine your search
Annals of surgical treatment and research 108:374-389 PubMed40503265
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4274 PubMed40393984
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:249 PubMed40133959
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science translational medicine 17:eadn6274 PubMed39970230
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 38:738-754 PubMed39168636
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of medicinal chemistry 67:15411-15427 PubMed39159487
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0299403 PubMed38489292
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:23038 PubMed38155155
2023
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 12: PubMed37507960
2023
Applications
Unspecified application
Species
Unspecified reactive species
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 22:2037-2053 PubMed37166570
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com